Sign In

Thibault Honegger

CEO & Co-founder at NETRI

Thibault Honegger is a scientist and entrepreneur with a strong background in bioengineering and biomedical engineering. He holds a Doctor of Philosophy from the Université Grenoble Alpes and an Engineer's degree from Ecole Centrale Nantes. He has worked as an associate researcher at CNRS - Centre national de la recherche scientifique and as a post-doc fellow at the Massachusetts Institute of Technology (MIT). Thibault has co-founded several startups, including Linkio SAS and Smart Force Technologies SAS. His latest venture is NETRI, where he serves as CEO and co-founder.

NETRI aims to accelerate the development of novel treatments for neurological disorders by designing, fabricating, and exploiting microfluidic technologies to reproduce neuronal circuits using physiologically relevant in vitro microfluidic neuro engineering. Their 14 Neurofluidic chips can perform assays to understand mode of action using rodent or human coupled to electeophysiological recordings.

Thibault Honegger's expertise lies in microfluidic technologies, neuroscience, bioengineering, biomedical engineering, and entrepreneurship. He is interested in bridging the gap between petri dish assays and in vivo experiments, designing and fabricating microfluidic technologies, and exploring the use of technology for medical applications.

Highlights

Jul 8 · linkedin

📢 Did you attend the MPS World Summit in June and/or EUROoCS Annual Meeting in July? Or maybe... You were unable to attend these conferences? Register for our webinar tomorrow, Tuesday July 9 (5:00 - 6:00 PM (CET)), for a follow-up of the 3rd edition of MPS World Summit and EUROoCS: Innervation and vascularization, Pumpless mono & multi organs-on-chip, Neurons as a sensor and AI predictability...

We are deligthed to host this webinair and share with you our latest data and approach following the discussion we had at MPS World Summit and/or EUROoCS.  🔸 A reminder of our innvervation and vascularization strategies using our NeuroFluidics, including MEA, and MultiFluidics lines. 🔸 Our approach of single and multi organoids & organs-on-chip without any pumps and compatible with high throughput data generation. 🔸 A wrap up of the presentation we gave at MPS World Summit and EUROoCS on using neurons as a digital biosensor in any organs, coupled to AI for enhanced predictablity of compounds.

🔍 3rd MPS World & EUROoCS Summit follow-up with Thibault Honegger and Thierry Poumeyrol 📅 Tuesday, July 9 🕙 5:00 - 6:00 PM (CET) 🔗

Jul 3 · linkedin

Can't wait to join EUROoCS in Milano ! I am sure Paola Occhetta and her team have made an incredible job.

We'll be also more than happy to introduce the French Organoid and Organ On Chip Initiative (F3OCI) with Jean-Dominique Guitton

Andries van der Meer Xavier Gidrol Fabrice Navarro BioValley France France Biotech

Related Questions

What is Lys Therapeutics' main focus?
How did Thibault Honegger and his team come up with the idea for Lys Therapeutics?
What are some of the key projects Thibault Honegger has worked on at NETRI?
How does Thibault Honegger's background in science influence his entrepreneurial ventures?
What is the significance of the partnership with Axion BioSystems for Lys Therapeutics?
Thibault Honegger
Thibault Honegger, photo 1
Thibault Honegger, photo 2
Add to my network

Location

Lyon, Auvergne-Rhône-Alpes, France